This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pihlajamäki, J. Articles by Laakso, M. Search for Related Content PubMed PubMed Citation Articles by Pihlajamäki, J. Articles by Laakso, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Triglycerides Related Collections Lipids Risk Factors Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:164.)
© 2000 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Impaired Free Fatty Acid Suppression During Hyperinsulinemia Is a Characteristic Finding in Familial Combined Hyperlipidemia, but Insulin Resistance Is Observed Only in Hypertriglyceridemic Patients

Jussi Pihlajamäki; Leena Karjalainen; Pauli Karhapää; Ilkka Vauhkonen; Markku Laakso

From the Department of Medicine, University of Kuopio, Kuopio, Finland.

Correspondence to Markku Laakso, MD, Professor and Chair, Department of Medicine, University of Kuopio, 70210 Kuopio, Finland. E-mail markku.laakso{at}uku.fi

Abstract—Insulin resistance has been associated with hypertriglyceridemia, combined hyperlipidemia, and familial combined hyperlipidemia (FCHL). Whether all FCHL patients with different types of dyslipidemia have low insulin sensitivity has not been evaluated. We measured insulin sensitivity by the hyperinsulinemic euglycemic clamp with indirect calorimetry in 110 healthy controls and in 105 nondiabetic, FCHL family members: in 50 without dyslipidemia, in 19 with hypercholesterolemia (total cholesterol 7.7 mmol/L), in 22 with hypertriglyceridemia (total triglycerides 2.4 mmol/L in men 2.4 mmol/L in women), and in 14 with combined hyperlipidemia. During the hyperinsulinemic clamp, FCHL family members had higher free fatty acid levels than did controls (0.06±0.06 [mean±SD] in controls versus 0.16±0.11 in relatives without dyslipidemia versus 0.15±0.07 in hypercholesterolemic patients versus 0.29±0.14 in hypertriglyceridemic patients versus 0.27±0.17 mmol/L in patients with combined hyperlipidemia; P<0.001 after adjustment for age, sex, and body mass index). Relatives without dyslipidemia (16.4±4.4 µmol · kg^-1 · min^-1, P=0.001) and patients with hypertriglyceridemia (12.8±3.8 µmol · kg^-1 · min^-1, P<0.001) and with combined hyperlipidemia (13.7±3.1 µmol · kg^-1 · min^-1, P<0.001) had lower rates of insulin-stimulated glucose oxidation than did controls (19.4±4.7 µmol · kg^-1 · min^-1). Also, the rates of nonoxidative glucose disposal were lower in patients with hypertriglyceridemia (P=0.001) and combined hyperlipidemia (P=0.011) than in controls. In contrast, subjects with hypercholesterolemia and control subjects had similar rates of insulin-stimulated glucose uptake. We conclude that a defect in free fatty acid suppression during hyperinsulinemia, probably located in adipose tissue, is characteristic for all FCHL patients with varying types of dyslipidemia, whereas insulin resistance in skeletal muscle is observed only in FCHL patients with elevated triglyceride levels.

Key Words: familial combined hyperlipidemia • insulin resistance • insulin • free fatty acids

This article has been cited by other articles:

				M.J. Veerkamp, J. de Graaf, and A.F.H. Stalenhoef Role of Insulin Resistance in Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 1026 - 1031. [Abstract] [Full Text] [PDF]

				C. Verseyden, S. Meijssen, H. van Dijk, H. Jansen, and M. C. Cabezas Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia J. Lipid Res., November 1, 2003; 44(11): 2100 - 2108. [Abstract] [Full Text] [PDF]

				P. N. Hopkins, G. Heiss, R. C. Ellison, M. A. Province, J. S. Pankow, J. H. Eckfeldt, and S. C. Hunt Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia: A Case-Control Comparison From the National Heart, Lung, and Blood Institute Family Heart Study Circulation, August 5, 2003; 108(5): 519 - 523. [Abstract] [Full Text] [PDF]

				A. Soro, M. Jauhiainen, C. Ehnholm, and M.-R. Taskinen Determinants of low HDL levels in familial combined hyperlipidemia J. Lipid Res., August 1, 2003; 44(8): 1536 - 1544. [Abstract] [Full Text] [PDF]

				A. Kubaszek, J. Pihlajamaki, P. Karhapaa, I. Vauhkonen, and M. Laakso The K121Q Polymorphism of the PC-1 Gene Is Associated With Insulin Resistance but not With Dyslipidemia Diabetes Care, February 1, 2003; 26(2): 464 - 467. [Abstract] [Full Text] [PDF]

				A. Kubaszek, J. Pihlajamaki, K. Punnonen, P. Karhapaa, I. Vauhkonen, and M. Laakso The C-174G Promoter Polymorphism of the IL-6 Gene Affects Energy Expenditure and Insulin Sensitivity Diabetes, February 1, 2003; 52(2): 558 - 561. [Abstract] [Full Text] [PDF]

				L. Luzi, G. Perseghin, G. Tambussi, E. Meneghini, P. Scifo, E. Pagliato, A. Del Maschio, G. Testolin, and A. Lazzarin Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E274 - E280. [Abstract] [Full Text] [PDF]

				J. Vakkilainen, M. Jauhiainen, K. Ylitalo, I. O. Nuotio, J. S. A. Viikari, C. Ehnholm, and M.-R. Taskinen LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins J. Lipid Res., April 1, 2002; 43(4): 598 - 603. [Abstract] [Full Text] [PDF]

				S. Meijssen, R. J. Derksen, S. Bilecen, D. W. Erkelens, and M. C. Cabezas In Vivo Modulation of Plasma Free Fatty Acids in Patients with Familial Combined Hyperlipidemia Using Lipid-Lowering Medication J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1576 - 1580. [Abstract] [Full Text] [PDF]

				J. Pihlajamaki, M. Austin, K. Edwards, and M. Laakso A Major Gene Effect on Fasting Insulin and Insulin Sensitivity in Familial Combined Hyperlipidemia Diabetes, October 1, 2001; 50(10): 2396 - 2401. [Abstract] [Full Text]

				H. Allayee, T. W.A. de Bruin, K. Michelle Dominguez, L. S.-C. Cheng, E. Ipp, R. M. Cantor, K. L. Krass, E. T.P. Keulen, B. E. Aouizerat, A. J. Lusis, et al. Genome Scan for Blood Pressure in Dutch Dyslipidemic Families Reveals Linkage to a Locus on Chromosome 4p Hypertension, October 1, 2001; 38(4): 773 - 778. [Abstract] [Full Text] [PDF]

				J. Q. Purnell, S. E. Kahn, R. S. Schwartz, and J. D. Brunzell Relationship of Insulin Sensitivity and ApoB Levels to Intra-abdominal Fat in Subjects With Familial Combined Hyperlipidemia Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 567 - 572. [Abstract] [Full Text] [PDF]

				S. Meijssen, M. C. Cabezas, T. B. Twickler, H. Jansen, and D. W. Erkelens In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia J. Lipid Res., July 1, 2000; 41(7): 1096 - 1102. [Abstract] [Full Text]